To determine the effect of THS exposure on leukemia/lymphoma risk, BM samples from THS-exposed and control Cdkn2a−/− mice were transplanted into BM ablated (irradiated) wildtype recipient mice, which were then followed for 1 year. This evidence concerns the gene CDKN2A and leukemia.